Trends and predictors of HPV vaccination among U.S. College women and men

Preventive Medicine

Volumn 86, Issue , 2016, Pages 92-98

  Thompson, Erika L ^a   Vamos, Cheryl A ^a   Vázquez Otero, Coralia ^a   Logan, Rachel ^a   Griner, Stacey ^a   Daley, Ellen M ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

College; HPV vaccination; Trends

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; ASIAN; BLACK PERSON; CAUCASIAN; COLLEGE STUDENT; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HISPANIC; HOMOSEXUAL MALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIRACIAL PERSON; PACIFIC ISLANDER; PRIORITY JOURNAL; SEX DIFFERENCE; TREND STUDY; UNITED STATES; VACCINATION; ADOLESCENT; AGE; PAPILLOMAVIRUS INFECTIONS; PREVENTIVE HEALTH SERVICE; PROCEDURES; STATISTICS AND NUMERICAL DATA; UNIVERSITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UNITED STATES; UNIVERSITIES; YOUNG ADULT;

EID: 84958252403     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2016.02.003     Document Type: Article

References (40)

1. American College Health Association American College Health Association-National College Health Assessment 2009-2013, American College Health Association, Hanover, MD, [computer file].
2. American College Health Association American College Health Association National College Health Assessment [cited 2014 September 15]; Available from. http://www.acha-ncha.org/.
3. Anhang Price R., Tiro J.A., Saraiya M., Meissner H., Breen N. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer 2011, 117(24):5560-5568.
4. Annie E Casey Foundation Kids count data center: young adults ages 18 to 24 enrolled in or completed college [cited 2015 June 28]; Available from. http://datacenter.kidscount.org/data/tables/77-young-adults-ages-18-to-24-enrolled-in-or-completed-college?loc=1&loct=1#detailed/1/any/false/36,868,867,133,38/any/388,389.
5. Bednarczyk R.A., Birkhead G.S., Morse D.L., Doleyres H., McNutt L.A. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine 2011, 29(17):3138-3143.
6. Bendik M.K., Mayo R.M., Parker V.G. Knowledge, perceptions, and motivations related to HPV vaccination among college women. J. Cancer Educ. 2011, 26(3):459-464.
7. Bernat D.H., Gerend M.A., Chevallier K., Zimmerman M.A., Bauermeister J.A. Characteristics associated with initiation of the human papillomavirus vaccine among a national sample of male and female young adults. J. Adolesc. Health 2013, 53(5):630-636.
8. Bynum S.A., Brandt H.M., Sharpe P.A., Williams M.S., Kerr J.C. Working to close the gap: identifying predictors of HPV vaccine uptake among young African American women. J. Health Care Poor Underserved 2011, 22(2):549-561.
9. Centers for Disease Control and Prevention FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. 2010, 59(20):630.
10. Centers for Disease Control and Prevention Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. 2011, 60(50):1705.
11. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am. J. Epidemiol. 2010, 171(3):357-367.
12. Dempsey A., Cohn L., Dalton V., Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 2011, 29(3):528-534.
13. Fontenot H.B., Fantasia H.C., Charyk A., Sutherland M.A. Human papillomavirus (HPV) risk factors, vaccination patterns, and vaccine perceptions among a sample of male college students. J. Am. Coll. Heal. 2014, 62(3):186-192.
14. Ford J.L. Racial and ethnic disparities in human papillomavirus awareness and vaccination among young adult women. Public Health Nurs. 2011, 28(6):485-493.
15. Gilbert P., Brewer N.T., Reiter P.L., Ng T.W., Smith J.S. HPV vaccine acceptability in heterosexual, gay, and bisexual men. Am. J. Mens Health 2011, 5(4):297-305.
16. H.zur Hausen Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2002, 2(5):342-350.
17. Healthy People 2020 Immunization and infectious diseases [cited 2015 December 15]; Available from. http://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives.
18. Hirth J.M., Tan A., Wilkinson G.S., Berenson A.B. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009. Cancer 2012, 118(22):5623-5629.
19. Insinga R.P., Dasbach E.J., Myers E.R. The health and economic burden of genital warts in a set of private health plans in the United States. Clin. Infect. Dis. 2003, 36(11):1397-1403.
20. Kharbanda E.O., Parker E., Nordin J.D., Hedblom B., Rolnick S.J. Receipt of human papillomavirus vaccine among privately insured adult women in a U.S. Midwestern Health Maintenance Organization. Prev. Med. 2013, 57(5):712-714.
21. Lacey C.J., Lowndes C.M., Shah K.V. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006, 24(Suppl. 3). (S3/35-41).
22. Laz T.H., Rahman M., Berenson A.B. Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer 2013, 119(7):1386-1392.
23. Liddon N.C., Leichliter J.S., Markowitz L.E. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am. J. Prev. Med. 2012, 42(1):44-52.
24. Lindley L.L., Elkind J.S., Landi S.N., Brandt H.M. Receipt of the human papillomavirus vaccine among female college students in the United States, 2009. J. Am. Coll. Heal. 2013, 61(1):18-27.
25. Markowitz L., Dunne E., Saraiya M., Lawson H., Chesson H., Unger E. Quadrivalent human papillomavirus vaccine. MMWR Morb. Mortal. Wkly Rep. 2007, 56(RR-2):1-24.
26. Markowitz L.E., Hariri S., Lin C., et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition examination surveys, 2003-2010. J. Infect. Dis. 2013, 208(3):385-393.
27. Munoz N., Bosch F.X., de Sanjose S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348(6):518-527.
28. Newman P.A., Logie C.H., Doukas N., Asakura K. HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex. Transm. Infect. 2013, 89(7):568-574.
29. Petrosky E., Bocchini J.A., Hariri S., et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on immunization practices. MMWR Morb. Mortal. Wkly Rep. 2015, 64(11):300-304.
30. Pierre-Victor D., Mukherjee S., Bahelah R., Madhivanan P. Human papillomavirus vaccine uptake among males 11-26 years in United States: findings from the National Health and Nutrition Examination Survey, 2011-2012. Vaccine 2014, 32(49):6655-6658.
31. Rahman M., Islam M., Berenson A.B. Differences in HPV immunization levels among young adults in various regions of the United States. J. Community Health 2015.
32. Richman A.R., Haithcox-Dennis M.J., Allsbrook A.R. Feasibility of a catch-up HPV vaccination program among college students attending a large rural university in the south. Am. J. Sex Educ. 2012, 7(3):237-252.
33. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29(5):890-895.
34. Satterwhite C.L., Torrone E., Meites E., et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex. Transm. Dis. 2013, 40(3):187-193.
35. Schmidt S., Parsons H.M. Vaccination interest and trends in human papillomavirus vaccine uptake in young adult women aged 18 to 26 years in the United States: an analysis using the 2008-2012 National Health Interview Survey. Am. J. Public Health 2014, 104(5):946-953.
36. Thompson E.L. The Influence of Relationship Status on HPV Vaccine Decision-Making among Young Adult Women 2015, University of South Florida, Tampa, FL.
37. Tiro J.A., Tsui J., Bauer H.M., Yamada E., Kobrin S., Breen N. Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey. J. Womens Health (Larchmt) 2012, 21(6):656-665.
38. Wei F., Moore P.C., Green A.L. Geographic variability in human papillomavirus vaccination among U.S. young women. Am. J. Prev. Med. 2013, 44(2):154-157.
39. Williams W.W., Lu P.J., Saraiya M., et al. Factors associated with human papillomavirus vaccination among young adult women in the United States. Vaccine 2013, 31(28):2937-2946.
40. Williams W.W., Lu P.J., O'Halloran A., et al. Vaccination coverage among adults, excluding influenza vaccination - United States, 2013. MMWR Morb. Mortal. Wkly Rep. 2015, 64(4):95-102.